Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.